Last reviewed · How we verify

NCT04936165

Circulation and Oxygenation Changes of Deep Tissue Respond on LLLT

Status unknown NA Last updated 23 June 2021
What this trial tests

NA trial testing Low-Level Laser Therapy in Low Level Light/Laser Therapy in 40 participants. Status unknown.

Timeline
25 June 2021
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorTing Li
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment40
Start date25 June 2021
Primary completion31 December 2021
Estimated completion31 December 2021
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Ting Li — full company profile →

Who can join

Adults 20 to 80, any sex, with Low Level Light/Laser Therapy or Near Infrared Spectroscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the circulation and oxygenation changes of deep tissue respond on low level light/laser therapy (LLLT) in the healthy population. The investigators used a self-made near infrared spectroscopy (NIRS) instrument to noninvasively monitor hemodynamic indicators of brain and forearm muscle groups, including total hemoglobin (\[tHb\]), and blood flow (BF) and oxygen consumption (VO2).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Low-Level Laser Therapy

Trials testing the same drug.

Other Ting Li trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04936165.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing